Copyright
©The Author(s) 2022.
World J Diabetes. Jul 15, 2022; 13(7): 498-520
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.498
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.498
Table 1 Major components of the glomerular basement membrane and the mesangial matrix in normal human glomeruli
| Glomerular basement membrane | Mesangial matrix | |
| Heparan sulfate proteoglycan | Abundant | Abundant |
| Laminin | Major component | Minor component |
| Fibronectin | Minor component | Major component |
| Type I collagen | Absent in most studies | Absent in most studies |
| Type III collagen | Absent in most studies | Absent in most studies |
| Type IV collagen | Major component | Present (inconsistent amounts) |
| Type V collagen | Present | Present |
| Type VI collagen | Present | Present |
| Type XVII collagen | Present | Unknown |
| Type XVIII collagen | Present | Present |
| Tubulointerstitial nephritis antigen-like-1 | Low abundance | High abundance |
| Nidogen / Entactin | Present | Low abundance |
| Fibulin-1 | Present | Present |
| Fibrillin-1 | Present | Present |
| Nephronectin | Present | Present |
| Vitronectin | Absent | Present |
| Microfibril-associated proteins | Absent | Present |
Table 2 Staining characteristics of the mesangial deposits in diabetic kidney diseases, fibronectin-1 nephropathy, and type III collagen glomerulopathy
| Periodic acid Schiff | Methenamine silver | Congo red | Specific analysis | |
| Diabetic kidney disease | Positive | Positive | Negative | Unknown material |
| Fibronectin-1 nephropathy | Positive | Negative | Negative | Fibronectin-1 |
| Type III collagen nephropathy | Negative | Negative | Negative | Type III collagen |
Table 3 Type IV collagen-related kidney disease
| Gene/location | Protein | Mutation | Risk of progression to end-stage kidney disease | |
| X-linked Alport syndrome | COL4A5/X chromosome | α5 chain of type IV collagen | Hemizygous (males) or heterozygous (females) mutations | Hemizygous: 100%; Heterozygous: 25% |
| Autosomal recessive Alport syndrome | COL4A4 or COL4A3/2q36-37 | α4 and α3 chains of type IV collagen | Biallelic (homozygous or compound heterozygous) mutations | 100% |
| Autosomal dominant Alport syndrome | COL4A4 or/COL4A32q36-37 | α4 and α3 chains of type IV collagen | Heterozygous mutations in the α4 or α3 chains | 20% in patients with risk factors for progression |
| Digenic Alport syndrome | Two of the COL4A3-5 genes | Two of the α3-5 chains |
Table 4 Different composition of glomerular extracellular matrix (glomerular basement membrane and mesangial matrix) in normal subjects and patients with diabetes
| Normal glomeruli | Diabetic kidney disease | |
| Heparan sulfate proteoglycans | GBM and mesangial matrix | Decreased amount |
| Laminin | Predominantly in the GBM | Inconsistent |
| Fibronectin-1 | Mainly in the mesangial matrix | It varies according to DKD stage |
| Type I collagen | Inconsistent | No detectable |
| Type III collagen | Absent | Abundant |
| Type IV collagen | Abundant in the GBM | Reduced GBM amount |
| Type V collagen | Similar to type IV collagen | Increased mesangial amount |
| Type VI collagen | GBM and mesangial matrix | Increased mesangial amount |
- Citation: Adeva-Andany MM, Carneiro-Freire N. Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease. World J Diabetes 2022; 13(7): 498-520
- URL: https://www.wjgnet.com/1948-9358/full/v13/i7/498.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i7.498
